Related Experiment Video
Updated: May 19, 2026

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
Published on: March 17, 2014
High PGE2 Levels Inhibit the Migration of Dendritic Cells by Modulating the PKA-CREB Axis Instead of Epac1-Rap1
Ge Diao1, Jie Huang1, Min Tian1
1Department of Gynaecology and Obstetrics, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China, tmmu.edu.cn.
Abstract:
The inhibited migration of dendritic cells (DCs) from lesion tissue to draining lymph nodes is a possible way for tumors to achieve immune evasion. In a previous study, we demonstrated that high concentrations of Prostaglandin E2 (PGE2), which were expressed in tumor microenvironments, inhibited DCs' migration. However, the specific mechanism is not yet clear. The current study aims to use the murine bone marrow-derived DCs (BMDCs) to demonstrate the possible signaling pathway of PGE2. The mRNA and protein expressions of the Epac1-Rap1 axis and PKA-CREB axis were determined after administration of PGE2 on DCs. Then, the agonist and antagonist of these molecules were used to treat DCs. The migration capability of DCs was detected as well as the RhoA activation levels. The mRNA and protein of Epac1 were barely undetectable in DCs. The use of Epac1 agonists showed no impact on DCs' migration capability and RhoA activation levels. The activation levels of Rap1 and protein expressions of Rap1a and Rap1b were not affected by PGE2 administration. The using of Rap1a and Rap1b antagonists demonstrated no impact on DCs' migration capability and RhoA activation levels. Moreover, the PKA activation levels and phosphorylated CREB1 were increased by the administration of PGE2 on DCs. The application of a PKA inhibitor attenuated the effect of PGE2 in a 3D migration assay and in vivo experiment. These results suggest that the PKA-CREB axis, instead of Epac1-Rap1, probably associates with the intracellular signaling pathway induced by high PGE2 levels, which demonstrates an inhibitory effect on DCs' migration. These findings can bring a different perspective on immunological surveillance of tumor progression.
Insights
High levels of Prostaglandin E2 (PGE2) in tumors inhibit dendritic cell (DC) migration by activating the PKA-CREB pathway, not the Epac1-Rap1 axis, impacting immune evasion.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Tumors can evade immune detection by preventing dendritic cell (DC) migration to lymph nodes.
- High concentrations of Prostaglandin E2 (PGE2) in the tumor microenvironment are known to inhibit DC migration, but the underlying mechanism remains unclear.
- Understanding this mechanism is crucial for developing strategies to enhance anti-tumor immunity.
Purpose of the Study:
- To elucidate the specific intracellular signaling pathway through which PGE2 inhibits the migration of murine bone marrow-derived DCs (BMDCs).
- To investigate the roles of the Epac1-Rap1 and PKA-CREB signaling axes in mediating PGE2's effect on DC migration.
Main Methods:
- BMDCs were treated with PGE2, and the expression of mRNA and proteins for the Epac1-Rap1 and PKA-CREB pathways was analyzed.
- Agonists and antagonists for Epac1, Rap1, and PKA were used to assess their impact on DC migration and RhoA activation.
- DC migration was evaluated using 3D migration assays and in vivo experiments, with RhoA activation levels also measured.
Main Results:
- Epac1 mRNA and protein were largely undetectable in BMDCs, and Epac1 agonists did not affect DC migration or RhoA activation.
- PGE2 did not alter Rap1 activation or the expression of Rap1a and Rap1b; Rap1 antagonists had no effect on DC migration.
- PGE2 significantly increased PKA activation and CREB1 phosphorylation in DCs. PKA inhibition reversed PGE2's inhibitory effect on DC migration.
Conclusions:
- The PKA-CREB signaling axis, rather than the Epac1-Rap1 axis, is implicated in the inhibition of DC migration by high PGE2 levels.
- These findings suggest a novel mechanism for tumor-induced immune evasion and offer potential targets for immunotherapy.
- The study provides a new perspective on immunological surveillance in the context of tumor progression.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCR Desensitization
IP3/DAG Signaling Pathway
